Lisata Therapeutics, Inc.
LSTA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000320017
No open-market purchases or sales by Lisata Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $3.70M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Lisata Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 34 | 36 | +2 |
| Shares | 8.81M | 9.43M | +625.7K (+7.1%) |
| Value | $6.13M | $5.00M | −$1.13M (−18.4%) |
New holders (5)
Institutions that held Lisata Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ra Capital Management, L.P. | 752,500 | $399.0K | 0.01% |
| IPG Investment Advisors LLC | 137,552 | $73.0K | 0.02% |
| Two Sigma Securities, LLC | 18,248 | $10.0K | 0.00% |
| Tarbox Family Office, Inc. | 11,542 | $6.00K | 0.00% |
| Spire Wealth Management | 1,087 | $1.00K | 0.00% |
Sold out (3)
Institutions that held Lisata Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Two Sigma Investments, LP | 94,333 | $68.0K |
| Citadel Advisors LLC | 18,044 | $13.0K |
| Simplex Trading, LLC | 18,885 | $13.0K |